Lipe & Dalton’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.06M | Sell |
8,092
-249
| -3% | -$58K | 0.96% | 36 |
|
|
2026
Q1 | $2.04M | Sell |
8,341
-599
| -7% | -$140K | 1.07% | 32 |
|
|
2025
Q4 | $1.85M | Sell |
8,940
-71
| -0.8% | -$14K | 0.91% | 35 |
|
|
2025
Q3 | $1.67M | Sell |
9,011
-199
| -2% | -$34.1K | 0.83% | 39 |
|
|
2025
Q2 | $1.41M | Buy |
9,210
+112
| +1% | +$17.2K | 0.76% | 42 |
|
|
2025
Q1 | $1.51M | Sell |
9,098
-559
| -6% | -$87.5K | 0.84% | 41 |
|
|
2024
Q4 | $1.4M | Buy |
9,657
+202
| +2% | +$31.3K | 0.74% | 39 |
|
|
2024
Q3 | $1.53M | Buy |
9,455
+1,312
| +16% | +$209K | 0.77% | 42 |
|
|
2024
Q2 | $1.19M | Buy |
8,143
+301
| +4% | +$44.8K | 0.64% | 46 |
|
|
2024
Q1 | $1.24M | Hold |
7,842
| – | – | 0.64% | 45 |
|
|
2023
Q4 | $1.23M | Sell |
7,842
-199
| -2% | -$30.5K | 0.67% | 44 |
|
|
2023
Q3 | $1.25M | Buy |
8,041
+600
| +8% | +$99K | 0.75% | 42 |
|
|
2023
Q2 | $1.23M | Buy |
7,441
+291
| +4% | +$47K | 0.7% | 45 |
|
|
2023
Q1 | $1.11M | Buy |
7,150
+1
| +0% | +$161 | 0.63% | 46 |
|
|
2022
Q4 | $1.26M | Buy |
7,149
+1
| +0% | +$173 | 0.73% | 43 |
|
|
2022
Q3 | $1.17M | Hold |
7,148
| – | – | 0.73% | 43 |
|
|
2022
Q2 | $1.27M | Buy |
7,148
+326
| +5% | +$58.1K | 0.74% | 41 |
|
|
2022
Q1 | $1.21M | Sell |
6,822
-278
| -4% | -$47.3K | 0.59% | 47 |
|
|
2021
Q4 | $1.22M | Sell |
7,100
-133
| -2% | -$21.8K | 0.57% | 46 |
|
|
2021
Q3 | $1.17M | Sell |
7,233
-24
| -0.3% | -$4.09K | 0.6% | 45 |
|
|
2021
Q2 | $1.2M | Buy |
7,257
+1
| +0% | +$166 | 0.62% | 46 |
|
|
2021
Q1 | $1.19M | Buy |
7,256
+96
| +1% | +$15.5K | 0.66% | 43 |
|
|
2020
Q4 | $1.13M | Buy |
7,160
+475
| +7% | +$70.1K | 0.69% | 44 |
|
|
2020
Q3 | $995K | Sell |
6,685
-124
| -2% | -$18.3K | 0.69% | 44 |
|
|
2020
Q2 | $958K | Buy |
6,809
+131
| +2% | +$19.1K | 0.7% | 43 |
|
|
2020
Q1 | $876K | Sell |
6,678
-315
| -5% | -$44.7K | 0.74% | 41 |
|
|
2019
Q4 | $1.02M | Sell |
6,993
-24
| -0.3% | -$3.25K | 0.68% | 42 |
|
|
2019
Q3 | $908K | Sell |
7,017
-524
| -7% | -$69K | 0.66% | 42 |
|
|
2019
Q2 | $1.05M | Sell |
7,541
-200
| -3% | -$27.7K | 0.75% | 43 |
|
|
2019
Q1 | $1.08M | Buy |
7,741
+2,501
| +48% | +$335K | 0.8% | 42 |
|
|
2018
Q4 | $676K | Buy |
5,240
+2,255
| +76% | +$315K | 0.55% | 45 |
|
|
2018
Q3 | $412K | Hold |
2,985
| – | – | 0.28% | 47 |
|
|
2018
Q2 | $362K | Buy |
2,985
+25
| +0.8% | +$3.12K | 0.27% | 47 |
|
|
2018
Q1 | $379K | Buy |
2,960
+37
| +1% | +$5K | 0.27% | 49 |
|
|
2017
Q4 | $408K | Hold |
2,923
| – | – | 0.28% | 47 |
|
|
2017
Q3 | $380K | Hold |
2,923
| – | – | 0.27% | 46 |
|
|
2017
Q2 | $387K | Buy |
2,923
+100
| +4% | +$12.8K | 0.25% | 50 |
|
|
2017
Q1 | $352K | Sell |
2,823
-400
| -12% | -$47.8K | 0.25% | 47 |
|
|
2016
Q4 | $371K | Sell |
3,223
-100
| -3% | -$11.6K | 0.26% | 48 |
|
|
2016
Q3 | $393K | Hold |
3,323
| – | – | 0.26% | 55 |
|
|
2016
Q2 | $403K | Hold |
3,323
| – | – | 0.28% | 55 |
|
|
2016
Q1 | $360K | Sell |
3,323
-500
| -13% | -$51.8K | 0.28% | 46 |
|
|
2015
Q4 | $393K | Sell |
3,823
-556
| -13% | -$55.9K | 0.32% | 44 |
|
|
2015
Q3 | $409K | Hold |
4,379
| – | – | 0.34% | 44 |
|
|
2015
Q2 | $427K | Hold |
4,379
| – | – | 0.31% | 45 |
|
|
2015
Q1 | $441K | Hold |
4,379
| – | – | 0.3% | 43 |
|
|
2014
Q4 | $458K | Sell |
4,379
-100
| -2% | -$10.5K | 0.31% | 45 |
|
|
2014
Q3 | $478K | Hold |
4,479
| – | – | 0.31% | 44 |
|
|
2014
Q2 | $469K | Hold |
4,479
| – | – | 0.29% | 42 |
|
|
2014
Q1 | $450K | Sell |
4,479
-1,356
| -23% | -$126K | 0.3% | 40 |
|
|
2013
Q4 | $534K | Sell |
5,835
-818
| -12% | -$75.4K | 0.36% | 39 |
|
|
2013
Q3 | $577K | Buy |
6,653
+1,525
| +30% | +$137K | 0.42% | 35 |
|
|
2013
Q2 | $440K | Buy |
+5,128
| New | +$435K | 0.37% | 37 |
|
Other funds holding JNJ
Lipe & Dalton's JNJ Position: Q2 2026 in Review
Lipe & Dalton reduced its Johnson & Johnson (JNJ) stake by 3% in Q2 2026, selling an estimated $58K and leaving 8,092 shares worth $2.06M. The position accounts for 0.96% of the portfolio, ranked #36.
Lipe & Dalton first reported a position in JNJ in Q2 2013 and has held it in 53 quarters since. 4,665 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.
- Lipe & Dalton held 8,092 shares of Johnson & Johnson worth $2.06M as of Q2 2026.
- Lipe & Dalton sold 249 Johnson & Johnson shares in Q2 2026, an estimated $58K.
- Johnson & Johnson made up 0.96% of Lipe & Dalton's portfolio in Q2 2026, its #36 holding.
- Lipe & Dalton first reported a position in Johnson & Johnson in Q2 2013 and has held it in 53 quarters since.
- 4,665 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.
Based on Lipe & Dalton's 13F filing for Q2 2026, filed 14 Jul 2026.